NON HODGKIN LYMPHOMA (NHL)
Clinical trials for NON HODGKIN LYMPHOMA (NHL) explained in plain language.
Never miss a new study
Get alerted when new NON HODGKIN LYMPHOMA (NHL) trials appear
Sign up with your email to follow new studies for NON HODGKIN LYMPHOMA (NHL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can radiation and an antibiotic make CAR-T therapy safer and more effective?
Disease control Not yet recruitingThis early-stage trial tests whether giving radiation therapy and the antibiotic vancomycin before standard CAR-T cell treatment is safe and doable for people with large B-cell lymphoma. About 14 adults whose lymphoma has come back or not responded to treatment will take part. Th…
Matched conditions: NON HODGKIN LYMPHOMA (NHL)
Phase: PHASE1 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
Ready-Made immune cells take on lymphoma and leukemia in first human trial
Disease control Not yet recruitingThis early-phase study tests ALA-101, a pre-made cell therapy that targets CD19 on cancer cells, in adults with certain types of non-Hodgkin lymphoma or leukemia. The main goal is to check safety and find the best dose. About 46 participants will receive the treatment and be moni…
Matched conditions: NON HODGKIN LYMPHOMA (NHL)
Phase: PHASE1 • Sponsor: Arovella Therapeutics Ltd • Aim: Disease control
Last updated May 04, 2026 16:29 UTC